Skip to content

Deciphera Pharmaceuticals, Inc.

CIK 0001654151

← back to feed
Revenue (TTM)
$160.06M
+21.9% YoY Q1 May 2024
Net Income (TTM)
−$322.13M
−8.9% YoY Q1 May 2024
EPS Diluted (TTM)
−$2.27
+3.4% YoY Q1 May 2024
Gross Margin
12.1%
Q1 May 2024
Operating Margin
-130.3%
Q1 May 2024
Net Margin
-201.3%
Q1 May 2024
Free Cash Flow (TTM)
−$224.22M
Q1 May 2024
Cash
$91.23M
Q1 May 2024
Total Debt
—
Q1 May 2024
Shares Outstanding
86.48M sh
Q1 May 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings